Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.46 |
| ▸ | KDM1A | O60341 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.43 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4252248 | 0.94 | CYP1A2 (0.51) | MMP13SMN1; SMN2HPGDTSHRHDAC1 | |
| SCHEMBL4248598 | 0.93 | HPGD (0.48) | SMN1; SMN2HPGDTSHRHDAC1KDM4E | |
| SCHEMBL444605 | 0.92 | HDAC1 (0.54) | MMP13SMN1; SMN2HPGDTSHRHDAC1 | |
| SCHEMBL4253905 | 0.89 | ALDH1A1 (0.45) | MMP13SMN1; SMN2HDAC1KDM1AGAA | |
| SCHEMBL443259 | 0.86 | HDAC1 (0.55) | MMP13SMN1; SMN2HPGDTSHRHDAC1 | |
| SCHEMBL416282 | 0.85 | HPGD (0.51) | SMN1; SMN2HPGDTSHRHDAC1KDM1A | |
| SCHEMBL4250488 | 0.85 | HPGD (0.54) | MMP13SMN1; SMN2HPGDTSHRHDAC1 | |
| SCHEMBL4254278 | 0.84 | HPGD (0.53) | MMP13SMN1; SMN2HPGDTSHRHDAC1 | |
| SCHEMBL4253149 | 0.84 | HPGD (0.48) | MMP13SMN1; SMN2HPGDTSHRHDAC1 | |
| SCHEMBL4247798 | 0.83 | HDAC3 (0.60) | SMN1; SMN2HPGDTSHRHDAC1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090023798-A1 | THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | PHARMACYCLICS, INC. (US) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023798-A1 | THIOHYDROXAMATES AS INHIBITORS OF HISTONE DEACETYLASE | HDAC1, HDAC8, HDAC3 | MMP13 1693/4885SMN1; SMN2 3469/4885HPGD 351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.